Back to Search
Start Over
Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464).
- Source :
-
Osteoporosis International . Jul2018, Vol. 29 Issue 7, p1511-1513. 3p. - Publication Year :
- 2018
-
Abstract
- Purpose: To comment on the latest technology appraisal of the National Institute for Clinical Excellence (NICE) in osteoporosis.Methods: Review of NICE Technology Appraisal (TA464) on bisphosphonate use in osteoporosis.Results: The NICE appraisal on bisphosphonate use in osteoporosis indicates that treatment with oral bisphosphonates may be instituted at a FRAX 10-year probability of major osteoporotic fracture above 1%. Implementation would mean that all women aged 50 years or older are deemed eligible for treatment, a position that would increase the burden of rare long-term side effects across the population.Conclusion: Cost-effectiveness thresholds for low-cost interventions should not be used to set intervention thresholds but rather to validate the implementation of clinically driven intervention thresholds. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 0937941X
- Volume :
- 29
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- Osteoporosis International
- Publication Type :
- Academic Journal
- Accession number :
- 130553365
- Full Text :
- https://doi.org/10.1007/s00198-018-4505-x